ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,149Medicare Part D Prescriptions Filled, Including Refills

Rank: 496 out of 1454

$412K Total Retail Price of All Prescriptions

Rank: 589 out of 1454

381 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,399 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
PRAVASTATIN SODIUM 250 216 1 12
ATENOLOL 216 188 2 18
SIMVASTATIN 209 198 3 1
OMEPRAZOLE 206 162 4 3
HYDROCHLOROTHIAZIDE 189 154 5 9
LISINOPRIL 185 179 6 4
METOPROLOL TARTRATE 175 149 7 10
GLIMEPIRIDE 174 126 8 33
METFORMIN HCL 165 119 9 8
AMLODIPINE BESYLATE 154 99 10 2
ATORVASTATIN CALCIUM 150 134 11 11
POTASSIUM CHLORIDE 147 125 12 15
LEVOTHYROXINE SODIUM 140 122 13 5
LOSARTAN POTASSIUM 137 94 14 14
NEXIUM 132 99 15 23
ZOLPIDEM TARTRATE 125 89 16 19
HYDROCODONE-ACETAMINOPHEN 118 84 S3 17 7
MELOXICAM 113 88 18 37
SERTRALINE HCL 111 85 19 26
ALLOPURINOL 101 87 20 28
ALENDRONATE SODIUM 94 94 21 35
FUROSEMIDE 93 78 22 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 88 23 27
TAMSULOSIN HCL 91 80 24 34
OXYCODONE-ACETAMINOPHEN 85 55 S2 25 60
METFORMIN HCL ER 75 66 26 41
LOVASTATIN 75 75 26 39
WARFARIN SODIUM 74 74 28 17
GABAPENTIN 70 27 29 16
METOPROLOL SUCCINATE 69 67 30 13
AZITHROMYCIN 68 52 31 42
KLOR-CON M20 63 39 32 54
OXYCODONE HCL 63 28 S2 32 80
FLUTICASONE PROPIONATE 61 40 34 30
ZETIA 60 59 35 69
LOSARTAN-HYDROCHLOROTHIAZIDE 56 40 36 38
TORSEMIDE 53 41 37 125
SPIRONOLACTONE 52 46 38 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.